Article Text

PDF
Some concerns and improvements from Turkey
  1. Olgu Erkin Cinar1,
  2. Abdulsamet Erden2,
  3. Alper Sari3,
  4. Berkan Armagan2,
  5. Levent Kilic2
  1. 1Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Ankara, Turkey
  2. 2Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
  3. 3Division of Rheumatology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
  1. Correspondence to Dr Olgu Erkin Cinar, Hacettepe Universitesi Tip Fakultesi, Ankara 06100, Turkey; drerkincinar{at}gmail.com

Statistics from Altmetric.com

First, thank you for this article which tries to answer a difficult clinical problem about anti-neutrophilic cytoplasmic antibody (ANCA)-associated vasculitis remission phase treatment.1 We believe that the study will be a milestone in ANCA-associated vasculitis maintenance treatment paradigm. To improve clinical implications, we wanted to ask about some important points in the study.

As seen in the literature,2 the Five Factor Score (FFS) is an easily …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.